Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 17 July 2027
- Last conf. stmt
- 3 July 2026
Orfonyx Bio Ltd
- Incorporated
- 4 July 2022 (4 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Christian Groendahl
- Owned by
- Accounts type
- Total exemption full
- Region
- South East
- Address
- Bioescalator Innovation BuildingRoosevelt DriveOxfordOX3 7FZ
Officers
This list may be incomplete. See all officers on Companies House
Officer details are public data from the Companies House register.
Groendahl, Christian, Dr
Director · Appointed 1 August 2026
Danish
Born September 1964 (62)
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 20 October 2022
Owns 75–100% of shares
Holds 75–100% of voting rights
Corporate
Reg. no. 09093331
Former controllers (3)
20 October 2022
Ceased Thomas Charles Roberts — Owns 25–50% of shares
20 October 2022
Ceased Nenad Svrzikapa — Owns 25–50% of shares
20 October 2022
Ceased Matthew John Andrew Wood — Owns 25–50% of shares
Group structure 18 shown
Ownership group derived from the Companies House PSC register
Acionna Therapeutics Ltd Owns 50–75% of shares
Animal Dynamics Limited Owns 50–75% of shares
Archangel Lightworks Ltd Owns 25–50% of shares
Ascension Earth Resources Ltd Owns 25–50% of shares
Caudal Energy Limited Owns 25–50% of shares
Caudal Morlais Limited Owns 75–100% of shares
Circadian Therapeutics Limited Owns 75–100% of shares
Cora Biosciences Limited Owns 25–50% of shares
Credo Therapies Ltd Owns 50–75% of shares
Densix Limited Owns 25–50% of shares
Dyna Therapeutics Limited Owns 50–75% of shares
Eligentis Limited Owns 25–50% of shares
Evox Therapeutics Limited Owns 25–50% of shares
Fluorok Limited Owns 25–50% of shares
Orfonyx Bio Ltd This company Owns 75–100% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £846,597
- Cash
- £494,191
- Employees
- 6
- Debt Ratio
- 13%
- Current Ratio
- 5.9x
Trend
Net Assets
Balance sheet detail
| 2024 | 2024 | 2023 | |
|---|---|---|---|
| Fixed Assets | £206,945 | £221,261 | £31,806 |
| Current Assets | £770,255 | £1,496,502 | £479,469 |
| Debtors | £276,064 | £269,017 | £127,777 |
| Cash | £494,191 | £1,227,485 | £351,692 |
| Creditors (< 1 year) | £130,603 | £177,768 | £107,889 |
| Net Current Assets | £639,652 | £1,318,734 | £371,580 |
| Net Assets | £846,597 | £1,539,995 | £403,386 |
| Shareholder Funds | £846,597 | £1,539,995 | £403,386 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 17 August 2026 | Total exemption full accounts | 31 December 2025 | ||
| 11 August 2026 | Appointment of a director |
Some other companies at this address
Other companies in this industry
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →